Study finds a surprising new role for a major immune regulator
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
SMART researchers find the enzyme RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.
MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.
A biotech entrepreneur, Koehler will help faculty and students launch startups and bring new products to market through the MIT Deshpande Center for Technological Innovation.
BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems.
SMART researchers combine rifaximin and clarithromycin to effectively restore the latter drug's efficacy.
C16 Biosciences, founded by MIT alumni, has developed a microbial oil to replace palm oil, whose production reaps environmental devastation.
Synthetic biology expert to succeed Angela Belcher as department head effective Aug. 1.
MIT-Novo Nordisk Artificial Intelligence Postdoctoral Fellows Program will support up to 10 postdocs annually over five years.
A new Jell-O-like material could replace metals as electrical interfaces for pacemakers, cochlear implants, and other electronic implants.
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
Tactile stimulation improved motor performance, reduced phosphorylated tau, preserved neurons and synapses, and reduced DNA damage, a new study shows.
The machine-learning algorithm identified a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings.